Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Welch Allyn climbs to #35 rank in "The Best Companies to Work For" in Mexico list

For the second consecutive year, The Gestion de Negocios named Welch Allyn, a leading global manufacturer of frontline medical products and solutions, to its list of "The Best Companies to Work For" in Mexico, the country's most comprehensive study of workplace culture. This year's ranking represented a leap of 42 spots, as the company moved from #77 in 2009 to #35 this year—a significant accomplishment for the Welch Allyn de Mexico factory that has only been in operation since 2006.

27 May 2010

Biomedical/Clinical Engineering practice improves healthcare: Health Association Nova Scotia

The week, May 23 to May 29, is National Biomedical/Clinical Engineering Appreciation Week and celebrations across the country are recognizing the importance of this field to improving healthcare and the contributions of its practitioners.

27 May 2010

Impax Laboratories, IGI Laboratories announce product development and supply agreement

Impax Laboratories, Inc. today announced that it has entered into a product development and supply agreement with IGI Laboratories, Inc., a formulation and manufacturing company. IGI will be responsible for developing two topical drug products, obtaining FDA marketing approvals, and manufacturing the commercial products.

27 May 2010

Jubilant Organosys announces repayment of FCCBs amounting to $50M and YTM of $19M

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company out of India, today announced the repayment of FCCBs amounting to US$ 50 million along with the YTM of US$ 19 million. The FCCBs were due for redemption on May 24, 2010.

26 May 2010

ifp Institut für Produktqualität sells molecular biological, PCR-based food test product line to QIAGEN

The Berlin-based diagnostics company ifp Institut für Produktqualität has sold its molecular biological, PCR-based food test product line to QIAGEN at a price not revealed. QIAGEN has purchased all the required patents and licences and will immediately begin to market and distribute the newly acquired portfolio of 70 molecular biological tests. With the support of this powerful and experienced partner in food diagnostics ifp can now make available its expertise in food analytics globally.

From QIAGEN Manchester Limited 26 May 2010

CEVEC, Pevion Biotech sign license option agreement for transient CAP-T cell expression technology

CEVEC Pharmaceuticals, the German developer of a novel human expression system derived from amniocytes, announced today the signing of an exclusive license option agreement with Pevion Biotech, the Swiss vaccine company. The agreement enables Pevion Biotech to exclusively use CEVEC's transient CAP-T™ cell expression technology to manufacture and commercialize a protein antigen for vaccination against a widespread human infectious disease.

26 May 2010

ReVision Optics receives $35 million in capital funding

ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received $35 million in capital funding. The Lake Forest, Calif.-based firm specializes in the research, development and manufacturing of custom products to correct and maintain near vision.

26 May 2010

Lumizyme receives FDA approval for patients with late-onset Pompe disease

The U.S. Food and Drug Administration approved Lumizyme (alglucosidase alfa) for patients ages 8 years and older with late-onset (non-infantile) Pompe disease, a rare genetic disorder.

26 May 2010

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.

25 May 2010

Exactech acquires Brighton Partners

Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has acquired Brighton Partners, Inc., the sole source supplier of the direct compression molded polyethylene bearings used exclusively in Exactech's flagship product, the Optetrak® knee replacement system.

25 May 2010

Genzyme signs consent decree of permanent injunction, agrees to disgorgement

Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations at its Allston, Mass., manufacturing facility and will turn over to the federal government $175 million in unlawful profits from the sale of products that were made at the plant, the U.S. Food and Drug Administration announced today.

25 May 2010

Genzyme finalizes terms for consent decree regarding Allston manufacturing plant

Genzyme Corporation announced today that the terms for the consent decree regarding the Allston manufacturing plant have been finalized. These terms are in line with the company's expectations announced last month. The consent decree is subject to approval by the United States District Court for the District of Massachusetts.

25 May 2010

Elite Pharmaceuticals acquires hydromorphone hydrochloride tablets from Mikah Pharma

Elite Pharmaceuticals, Inc. announced today the acquisition of a currently approved Abbreviated New Drug Application (ANDA) for hydromorphone hydrochloride 8 mg tablets from Mikah Pharma LLC. The hydromorphone hydrochloride tablets are the generic equivalent of Dilaudid® 8 mg.

25 May 2010

Groundwater contaminants present potential health concern

More than 20 percent of untreated water samples from 932 public wells across the nation contained at least one contaminant at levels of potential health concern, according to a new study by the U.S. Geological Survey.

24 May 2010

Lantheus Medical Imaging receives additional supply of Mo-99 for production of vital medical isotopes

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that it has received additional supply of molybdenum-99 (Mo-99) to produce vital medical isotopes for its TechneLite® (Technetium Tc99m Generator) generators as the result of a recent agreement between the Institute for Radioelements (IRE), Fleurus, Belgium, and the Nuclear Research Institute (NRI), Rez, Czech Republic.

21 May 2010

Vitacost.com announces expansion of operations in North Carolina

Vitacost.com, Inc., a leading online retailer and direct marketer of health and wellness products, today announced the groundbreaking for the expansion of its east coast manufacturing and distribution facility in Lexington, North Carolina.

21 May 2010

China BCT Pharmacy reports 5.2% increase in first-quarter 2010 revenue

China BCT Pharmacy Group, Inc., a leading pharmaceutical distributor, retail pharmacy, and manufacturer of pharmaceutical products in Guangxi Province, China, today announced results for the first quarter ended March 31, 2010.

21 May 2010

Prodigy Diabetes Care honored with Export Achievement Certificate

U.S. Deputy Commerce Secretary Ro Khanna honored Prodigy Diabetes Care, LLC with its Export Achievement Certificate today during a stop in Charlotte aimed at touting President Obama's national export initiative.

21 May 2010

HemaCare announces commercial cell therapy collection agreement with Dendreon

HemaCare Corporation today announced an agreement with Dendreon Corporation to provide cellular collection services in Los Angeles and Maine for their new autologous cellular immunotherapy, PROVENGE® (sipuleucel-T). This personalized medicine is Dendreon's lead product and is the first autologous cellular immunotherapy specifically designed to engage patients' own immune systems to treat cancer.

21 May 2010

Invida Group completes joint venture agreement with MUGI

Invida Group, the leading specialty biopharmaceutical company focused on the commercialization of healthcare products throughout Asia Pacific, today announced that it has completed a joint venture agreement with the Indonesian pharmaceutical manufacturer MUGI.

20 May 2010

Manufacturing News and Research

Further Reading

Welch Allyn climbs to #35 rank in "The Best Companies to Work For" in Mexico list

Biomedical/Clinical Engineering practice improves healthcare: Health Association Nova Scotia

Impax Laboratories, IGI Laboratories announce product development and supply agreement

Jubilant Organosys announces repayment of FCCBs amounting to $50M and YTM of $19M

ifp Institut für Produktqualität sells molecular biological, PCR-based food test product line to QIAGEN

CEVEC, Pevion Biotech sign license option agreement for transient CAP-T cell expression technology

ReVision Optics receives $35 million in capital funding

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Exactech acquires Brighton Partners

Genzyme signs consent decree of permanent injunction, agrees to disgorgement

Genzyme finalizes terms for consent decree regarding Allston manufacturing plant

Elite Pharmaceuticals acquires hydromorphone hydrochloride tablets from Mikah Pharma

Groundwater contaminants present potential health concern

Lantheus Medical Imaging receives additional supply of Mo-99 for production of vital medical isotopes

Vitacost.com announces expansion of operations in North Carolina

China BCT Pharmacy reports 5.2% increase in first-quarter 2010 revenue

Prodigy Diabetes Care honored with Export Achievement Certificate

HemaCare announces commercial cell therapy collection agreement with Dendreon

Invida Group completes joint venture agreement with MUGI

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News